Don't post ridiculous false info mtd, you almost want to earn my ignore list. Post relevant info please. If you have a link to verify any of the lofty claims...please show them, as your as bad a basher.
Go to original Daily Mail article-- some one Commented said 29$. But I don't trust it.
However,Joe Z. has stated 30$ last year.With NCE uncertainty--offer under 30$ is likely.
As far as reliable source--if someone is going to leak--they will do it to newsmedia.
What I can say_ Pfizer sales dropped from 67.4 bil.$ in 2011 to 59.5 bil.$ in 2012 ESTIMATE.
Also AZN sold the rights to Nexium over the counter sales to Pfizer from 2014.Their sales force is busy launching Amylin diabetic drug. AZN sales also dropped from 33.6 bil.$ in 2011 to 28.2 bil.$ in 2012(ESTIMATE).
PFIZER has excess capacity for marketing as will GSK.
So my logic is --someone who can turn Vascepa into a BIG Success in 2013.